The conclusion drawn from the study is that SIRT7 could be a valuable target for glioma treatment, as inhibiting sirtuin 7 may reduce glioma cell proliferation and invasion, potentially improving patient outcomes [146]. The gene discussed is SIRT7; the disease is glioma.